Effective Delivery of PEGylated siRNA-Containing Lipoplexes to Extraperitoneal Tumours following Intraperitoneal Administration
Journal of Drug Delivery · 2011
DOI: 10.1155/2011/192562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Delivery, 2011. Verfasst von Akul Singhania und 2 weiteren Autor:innen. Beteiligte Einrichtung: The University of Queensland Diamantina Institute, Princess Alexandra Hospital, The University of Queensland, Woolloongabba, QLD 4102, Australia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: National Health and Medical Research Council, Australian Cancer Research Foundation, Cancer Council Queensland.
Abstract (Originalsprache)
Intraperitoneal (i.p.) administration of small interfering RNA (siRNA) has, to date, shown promise in treating tumours located within the peritoneal cavity. The ability of these siRNA molecules to reach extraperitoneal tumours following i.p. administration is, however, yet to be investigated. Here, we examined the impact of PEGylation on the biodistribution of i.p. administered nucleic acids-containing lipoplexes. We showed that in contrast to non-PEGylated liposomes, PEGylated liposomes can deliver siRNA efficiently to extraperitoneal tumours following i.p. administration, resulting in a 45% reduction in tumour size when the oncogene-targeted siRNA was used. This difference was likely contributed by the decreased uptake of PEGylated lipoplexes in the first-pass organs, and, in particular, we observed a 10-fold decrease in the macrophage uptake of these particles compared to non-PEGylated counterparts. Overall, our results indicated the potential of using PEGylated liposomes to deliver siRNA for the treatment of i.p. localized cancer with coexisting extraperitoneal metastasis.
Autor:innen und Institutionen
- The University of Queensland Diamantina Institute, Princess Alexandra Hospital, The University of Queensland, Woolloongabba, QLD 4102, Australia.
Förderung
- National Health and Medical Research Council
- Australian Cancer Research Foundation
- Cancer Council Queensland
Zitieren
APA
Singhania, A., Wu, S. Y., & McMillan, N. A. (2011). Effective Delivery of PEGylated siRNA-Containing Lipoplexes to Extraperitoneal Tumours following Intraperitoneal Administration. Journal of Drug Delivery. https://doi.org/10.1155/2011/192562
Vancouver
Singhania A, Wu SY, McMillan NA. Effective Delivery of PEGylated siRNA-Containing Lipoplexes to Extraperitoneal Tumours following Intraperitoneal Administration. Journal of Drug Delivery. 2011. doi:10.1155/2011/192562
BibTeX
@article{Singhania2011,
author = {Singhania, Akul and Wu, Sherry Y and McMillan, Nigel A J},
title = {Effective Delivery of PEGylated siRNA-Containing Lipoplexes to Extraperitoneal Tumours following Intraperitoneal Administration},
journal = {Journal of Drug Delivery},
year = {2011},
doi = {10.1155/2011/192562}
}
EUVIMED